Our law firm is reviewing da Vinci robotic surgery lawsuits. I have been writing critically about this medical device and its manufacturer, Intuitive Systems.
Much of my commentary has been of the, “This is really cool technology that they are misusing and one day this will be really great” variety. But a new study is making me question even that premise.
The vaginal mesh cases are heating up everywhere as plaintiffs’ lawyers, who frankly smell blood, are pushing with greater vigor to get and hold trial dates. Multi-million dollar verdicts will do that.
In the Boston Scientific transvaginal mesh cases, lawyers are pushing fast to get a trial date and are expected to get one soon. How do you define “soon” in tort law? Early next year.
All these federal cases have been consolidated in an MDL under a good judge in West Virginia. The class action lawsuit against Boston Scientific contents the mesh that was supposed to protect them from pelvic organ prolapse or stress urinary incontinence has done nothing but make their health problems far worse.
Earlier this month, the first federal NuvaRing lawsuit was delayed because there has been a lot of talk about settling not only that NuvaRing case, but all of the cases at one time. This blog post is about:
Medtonic is a large research company that holds itself out as a company that creates new and innovative ways to treat and rehabilitate patients around the world. This is true. But, too often, their innovation flops miserably because they put a product on the market that is not ready, or because they push a product to be used in ways that it should not be used.
In 2002 they introduced an Infuse Bone Graft procedure that uses recombinant human bone proteins to foster the growth and connection of broken bones. It is currently approved for use in anterior lumbar interbody fusion, tibial fractures, and sinus augmentations.
Smith & Nephew knee replacements are failing at an unacceptable rate
Our lawyers are investigating knee replacement lawsuits against Smith & Nephew.
These knee replacements have been on the market for some time. The reason for the lawsuits is simply: the Smith & Nephew knee replacements are simply failing at an unacceptable rate. These were supposed to be knee replacements that would last for 10 to 20 years. Patients who have these devices implanted may be entitled to revision surgery, medical expenses, lost wages and pain and suffering damages.
We recently reported on a study that revealed that the metal-on-metal hip replacements failed three times more often than other artificial hips. In fact, the U.S. Food and Drug Administration (FDA) ordered twenty-one (21) artificial hip manufacturers to conduct studies of the Metal-on-metal (MoM) hip replacement devices, and how they can adversely affect patients, after having received close to 11,000 reports of defective hip failures from January through September 2011.
All of this concern may be for nothing, as findings of a new study reveal that the all-metal artificial hip replacements provide no advantage when compared to older types of hip implants – they just appear to carry a greater risk of problems.
FDA researchers just published a report in the British Medical Journal in which the effectiveness of a number of types of hip implants was examined. Metal-on-metal hip implants were examined, as were ceramic-on-ceramic implants, and they were compared to the older metal on polyethylene implants and ceramic on polyethylene implants. The comparative study looked at 3,139 patients in 18 comparative studies. Data from 83,000 operations worldwide was reviewed.
Lawsuit Information Center